Showing results (271-280 of 289) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trialEdward Chow, Ralph M Meyer, Bingshu E Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 31, 2015
Predictive model for survival in patients having repeat radiation treatment for painful bone metastasesEdward Chow, Keyue Ding, Wendy R Parulekar, et al.
The Lancet. Oncology|December 27, 2013
Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trialEdward Chow, Yvette M van der Linden, Daniel Roos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 25, 2015
Revisiting classification of pain from bone metastases as mild, moderate, or severe based on correlation with function and quality of lifeEdward Chow, Keyue Ding, Wendy R Parulekar, et al.
Annals of Palliative Medicine|November 22, 2017
Gender differences in pain and patient reported outcomes: a secondary analysis of the NCIC CTG SC. 23 randomized trialSelina Chow, Keyue Ding, Bo Angela Wan, et al.
The American Journal of Hospice & Palliative Care|September 28, 2017
Patient Reported Outcomes After Radiation Therapy for Bone Metastases as a Function of Age: A Secondary Analysis of the NCIC CTG SC-Twenty-Three Randomized TrialSelina Chow, Keyue Ding, Bo Angela Wan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 6, 2017
Gender and age make no difference in the re-irradiation of painful bone metastases: A secondary analysis of the NCIC CTG SC.20 randomized trialRonald Chow, Keyue Ding, Vithusha Ganesh, et al.
Oncogene|January 5, 2016
Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progressionR Rupaimoole, C Ivan, D Yang, et al.
Pageof 29